MedPath

A Clinical study to assess the effect of Ayurvedic treatment comprising Madhutailika Basti Dhanyamla dhara and Atibalamoola & Bhoomyamalaki drugs in the patient of Diabetic polyneurotpathy

Phase 3
Completed
Conditions
Health Condition 1: null- Diabetes Mellitus type 2 Diabetic PolyneuropathyHealth Condition 2: E114- Type 2 diabetes mellitus with neurological complicationsHealth Condition 3: E114- Type 2 diabetes mellitus with neurological complications
Registration Number
CTRI/2017/04/008367
Lead Sponsor
Institute for Post graduate teaching and research in Ayurveda Gujarat Ayurved University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
99
Inclusion Criteria

1. Longstanding and uncontrolled Diabetes mellitus

along with the presence of symptoms and signs

of Diabetic peripheral neuropathy

(polyneuropathy).

2. Symptoms may include:

a.) Decreased sensation

b.) Positive neuropathic sensory symptoms

predominantly in the toes, feet or legs.

3. Signs may include:

a.) Decreased distal sensation

b.) Unequivocally decreased or absent ankle

reflexes.

Exclusion Criteria

Patients with -

1. Ischemic heart diseases

2. Non-Diabetic Neuropathies

3. Acute complications of DM

4. Any kind of infection

5. Diabetic foot

6. Piles

7. Fissures

8. Fistulas

9. Myocardial Infarction

10.Cerebrovascular event

11.Cardiac arrhythmias

12.Pregnancy

13.Active malignant disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Toronto Clinical Scoring System (TCSS) for Diabetic PolyneuropathyTimepoint: 45 days
Secondary Outcome Measures
NameTimeMethod
Quality of lifeTimepoint: 45 days
© Copyright 2025. All Rights Reserved by MedPath